Open Access

Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis

  • Authors:
    • Hui Yu
    • Bin Lin
    • Yongzhi He
    • Wenbin Zhang
    • Yang Xu
  • View Affiliations

  • Published online on: March 17, 2015     https://doi.org/10.3892/etm.2015.2368
  • Pages: 1631-1638
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The host response to spinal cord injury (SCI) can lead to an ischemic environment that can induce cell death. Therapeutic interventions using neurotrophic factors have focused on the prevention of such reactions in order to reduce this cell death. Vascular endothelial growth factor (VEGF) is a potent angiogenic and vascular permeability factor. We hypothesized in this study that batroxobin would exhibit protective effects following SCI by promoting the expression of VEGF to reduce the levels of apoptosis in a rat model of SCI. Ninety adult female Sprague Dawley rats were divided randomly into sham injury (group I), SCI (group II) and batroxobin treatment (group III) groups. The Basso‑Bettie‑Bresnahan (BBB) scores, number of apoptotic cells and expression of VEGF were assessed at 1, 3, 5, 7, 14 and 28 days post‑injury. The BBB scores were significantly improved in group III compared with those in group II between days 5 and 28 post‑injury (P<0.05). At each time‑point subsequent to the injury, the number of apoptotic cells in group III was reduced compared with that in group II. Compared with group II, treatment with batroxobin significantly increased the expression of VEGF from day 3 until 2 weeks post‑SCI (P<0.05), while no significant difference was observed at day 28. These data suggest that batroxobin has multiple beneficial effects on SCI, indicating a potential clinical application.
View Figures
View References

Related Articles

Journal Cover

May-2015
Volume 9 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu H, Lin B, He Y, Zhang W and Xu Y: Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis. Exp Ther Med 9: 1631-1638, 2015.
APA
Yu, H., Lin, B., He, Y., Zhang, W., & Xu, Y. (2015). Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis. Experimental and Therapeutic Medicine, 9, 1631-1638. https://doi.org/10.3892/etm.2015.2368
MLA
Yu, H., Lin, B., He, Y., Zhang, W., Xu, Y."Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis". Experimental and Therapeutic Medicine 9.5 (2015): 1631-1638.
Chicago
Yu, H., Lin, B., He, Y., Zhang, W., Xu, Y."Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis". Experimental and Therapeutic Medicine 9, no. 5 (2015): 1631-1638. https://doi.org/10.3892/etm.2015.2368